SH

Shoichi Hazama

CY Cytlimic: 5 patents #3 of 6Top 50%
TC Toyo Kohan Co.: 4 patents #63 of 295Top 25%
YU Yamaguchi University: 4 patents #13 of 132Top 10%
NE Nec: 1 patents #7,889 of 14,502Top 55%
Overall (All Time): #494,764 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11692216 Method for assisting prediction of risk of occurrence of side effect of irinotecan Masaaki Oka, Ryouichi Tsunedomi 2023-07-04
11618770 MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same Tomoya Miyakawa, Masaaki Oka, Koji Tamada, Keiko Udaka 2023-04-04
11384385 Method for predicting therapeutic effects of irinotecan, and kit for same Ryouichi Tsunedomi, Hiroaki Nagano 2022-07-12
11304997 HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell Tomoya Miyakawa, Masaaki Oka, Koji Tamada, Keiko Udaka 2022-04-19
11111526 Buffer composition for hybridization and hybridization method Toshiya Tsuda, Shuichi Kamei, Mitsuyoshi Oba, Hirofumi Yamano, Ryouichi Tsunedomi +1 more 2021-09-07
10875900 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells Tomoya Miyakawa, Masaaki Oka, Koji Tamada, Keiko Udaka 2020-12-29
10590179 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells Tomoya Miyakawa, Masaaki Oka, Koji Tamada, Keiko Udaka 2020-03-17
10537626 HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell Tomoya Miyakawa, Masaaki Oka, Koji Tamada, Keiko Udaka 2020-01-21
10526388 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells Tomoya Miyakawa, Masaaki Oka, Koji Tamada, Keiko Udaka 2020-01-07
10450601 Buffer composition for hybridization use, and hybridization method Shuichi Kamei, Mayuko Hosoya, Masaaki Oka, Ryouichi Tsunedomi 2019-10-22